Additional file 7: of Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer

Table S2. Analysis of screen and TCGA data. (a) NGS analysis with MaGeck (significant candidate sgRNAs with FDR cutoff 0.1 and high_in_treatment = true). (b) list of converted screen sgRNA candidates to official gene symbols, (c) Candidate genes with clinical amplification on CNA based on Comprehensive analysis of muscle-invasive bladder cancers characterized by multiple TCGA analytical platforms on CbioPortal. (XLSX 9460 kb)